Newly Diagnosed with Cancer? Remember You’re 'Not a Statistic'

Video

It's easy to get lost in the statistics of survivorship, but it's important for newly diagnosed patients with cancer to remember that they are not a statistic.

After being diagnosed with stage 1 triple-negative breast cancer (TNBC) in 2011, and stage 4 metastatic TNBC in 2016, Janice Cowden has learned firsthand that she is not a statistic – and she wants others who may be in a similar situation to know this, too.

In a recent interview with CURE®, Cowden and her husband and caregiver, Rex, spoke about how the facts and figures about survival rates in some cancer types can frighten newly diagnosed individuals, and how Janice made a habit of avoiding them, focusing instead on living in the present day.

“Our cancers are as unique as we are as individuals,” she says. “I think it's important to not look at the statistics and to not just assume that you are that statistic and that you're going to fit in those parameters of those statistics.”

“I realized that what I had to do to make each day good and livable was to plan to live that day.”

Transcription:

I think for me, what I have learned that I think I would share with someone who's newly diagnosed, regardless of their receptor type is that we're not a statistic. And our cancers are as unique as we are as individuals, our response to treatment is also as unique. So, I think it's important to not look at the statistics and to not just assume that you are that statistic and that you're going to fit in those parameters of those statistics.

I'm very fortunate. My oncologists never put a calendar date on me (or my survival). They, neither one of them, have ever said anything about a statistical prognosis for me. First of all, I think they realized that I read and research a lot, and they know that I can read that for myself. But there are so many people, especially newly diagnosed, that I think they automatically assume the worst. They plan to die, rather than planning to live.

And I think for the most part, once I reached a level of, I'm going to call it acceptance with this disease – and that came within the first six to 12 months after being diagnosed – I realized that what I had to do to make each day good and livable was to plan to live that day.

You know, I'm not dead yet. I'm probably not going to die tomorrow, or least not from this disease. And so, I think it's important to wake up and realize that each day is a gift.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of Kristen Dahlgren at Extraordinary Healer.
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.